Document Detail

Oral morphine as symptomatic treatment of dyspnoea in patients with advanced cancer.
MedLine Citation:
PMID:  9373578     Owner:  NLM     Status:  MEDLINE    
We report an open, uncontrolled study to evaluate the effectiveness of regular oral morphine as symptomatic treatment of dyspnoea in patients with advanced cancer receiving standard clinical care. Fifteen patients were assessed initially, and then 48 h and 7-10 days after starting treatment with oral morphine or having their dose increased. Dyspnoea, measured on a visual analogue scale (0-100), fell by a median of 14 (95% confidence interval -1.5, 25.5; Wilcoxon statistic 32.0; P = 0.06) in the nine who completed all three assessments. The three patients who died during the study did not show symptomatic benefit and, like the three who withdrew, experienced increased sedation and/or dizziness. Sedation was significantly increased at 48 h; median rise 10.5 (95% confidence interval 7, 25; Wilcoxon statistic 74; P = 0.007). Baseline respiratory function (FEV1, FVC, peak flow) was poor and the patients' respiratory rate was unaffected. Regular, titrated oral morphine may improve dyspnoea in some patients with advanced cancer but can cause significant short-term adverse effects. Oral morphine should be given to these patients as a therapeutic trial. Patients should be advised about side-effects and carefully monitored. Larger studies are needed to establish which patients are most likely to benefit and optimal dosage regimens.
K J Boyd; M Kelly
Related Documents :
11878738 - Postoperative analgesia by epidural methylprednisolone after posterolateral thoracotomy.
12538198 - A comparison of multimodal perioperative analgesia to epidural pain management after ga...
17894588 - Comparison of analgesic efficacy of preoperative or postoperative carprofen with or wit...
20504378 - Etoricoxib--preemptive and postoperative analgesia (eppa) in patients with laparotomy o...
16385088 - Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation...
20927548 - Comparative study of balloon and metal olive dilators for endoscopic management of beni...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Palliative medicine     Volume:  11     ISSN:  0269-2163     ISO Abbreviation:  Palliat Med     Publication Date:  1997 Jul 
Date Detail:
Created Date:  1997-12-08     Completed Date:  1997-12-08     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8704926     Medline TA:  Palliat Med     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  277-81     Citation Subset:  IM    
St Christopher's Hospice, London, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Oral
Aged, 80 and over
Analgesics, Opioid / administration & dosage*
Dyspnea / drug therapy*,  etiology,  physiopathology
Lung Neoplasms / complications*
Morphine / administration & dosage*
Palliative Care / methods*
Respiratory Mechanics
Reg. No./Substance:
0/Analgesics, Opioid; 57-27-2/Morphine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Nebulized morphine in the palliation of dyspnoea.
Next Document:  Disclosure of concerns by hospice patients and their identification by nurses.